|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A doseescalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men 显示文摘 | Gajjar D A LaCreta F P Uderman H D | 2000 | Pharmacotherapy2000，20，62： | 2 |
| 2 | Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid显示文摘 | O'DWYER P J LACRETA F NASH S | 1991 | Cancer Res1991，51，： | 1 |
| 3 | High performance liquid chromatographic analysis of fluoropyrimidine nucleosides and fluorouracil in plasma显示文摘 | Lacreta FP Williams WM | 1987 | J Chromatog B Biomed Appl1987，414，： | 1 |
| 4 | Effect of multiple-dose gatifloxacin or c iprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise显示文摘 | Gajjar DA LaCreta FP Kollia GD | | 0，，： | 1 |
| 5 | A dose-escalation study of the safety ,tolera bility ,and pharmacokinetics of intravenous gatifloxacin in healthy adult men显示文摘 | Gajjar DA’Lacreta FP Uderman HD | 2000 | Pharmacotherapy2000，20，62： | 1 |
| 6 | Interchangeability of 400mg intravenous and oral gatifloxacin in healthy adults显示文摘 | Kaul S Kollia GD | 2000 | Pharmacotherapy2000，20，62： | 1 |
| 7 | A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men显示文摘 | Lacreta FP Uderman HD | 2000 | Pharmacotherapy2000，20，62： | 1 |
| 8 | Age and gender effects on the pharmacokinetics of gatifloxacin显示文摘 | Kollia GD Duncan G | 2000 | Pharmacotherapy2000，20，62： | 1 |
| 9 | Open-label,nonrandomized study of the effects of gatifloxacin on the pharmacokinetics of midazolam in healthy male volunteers显示文摘 | Lacreta FP Kollia GD | 2000 | Pharmacotherapy2000，20，3： | 1 |
| 10 | High performance liquid chromatographic analysis of fluoropyrimidine nucleosides and fluorouracil in plasma显示文摘 | Lacreta FP Williams WM | 1987 | J Chromatog1987，414，： | 1 |
| 11 | Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer 显示文摘 | Hamilton TC LaCreta FP | 1996 | J Clin Oncol1996，14，1： | 1 |
| 12 | Stereoselective pharmacokinetics of L-buthionine-SR-sulfoximine in patients with cancer 显示文摘 | Brennan JM Hamilton TC | 1994 | Drug Meta Disp1994，26，6： | 1 |
| 13 | Interchangeability of 400mg intravenous and oral gatiflixacin in healthy adults显示文摘 | Lacreta FP Kaul S Kolllia GD | 2000 | Pharmacotherapy2000，20，： | 1 |
| 14 | Phase I/pharmacokinetic study of topotecan by 24- hour continuous infusion weekly 显示文摘 | HAAS N B LACRETA F P WALCZAK J | 1994 | Cancer Res1994，54，： | 1 |
| 15 | A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men显示文摘 | Gajjar DA LaCreta FP Uderman HD | 2000 | Pharmacotherapy2000，20，62： | 1 |
| 16 | Simultaneous oral therapeutic and intravenous <sup>14</sup>C‐microdoses to determine the absolute oral bioavailability of saxagliptin and dapagliflozin显示文摘 | David W. Boulton Sreeneeranj Kasichayanula Chi Fung (Anther) Keung Mark E. Arnold Lisa J. Christopher Xiaohui (Sophia) Xu Frank LaCreta | 2013 | Br J Clin Pharmacol2013，，3： | 1 |
| 17 | Interchangeability of 400mg intravenousand oral gati floxacin in healthyadults显示文摘 | Lacreta FP Kaul S Kollia GD | 2000 | Pharmacotherapy2000，20，62： | 1 |
| 18 | A dose-escalationstudy of the safety, tolerability, and pharmacokinetics of intravenousgatifloxacin in healthy adult men显示文摘 | Gajjar DA Lacreta FP Uderman HD | 2000 | Pharmacotherapy2000，20，62： | 1 |
| 19 | Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise 显示文摘 | Gajjar DA LaCreta FP Kollia GD | 2000 | Pharmacotherapy2000，20，62： | 1 |
| 20 | Pharmacologic study of etoposide and cisplatin by the intraperitoneal route显示文摘 | O'DWYER P J LACRETA F HOGAN M | 1991 | J Clin Pharmacol1991，31，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员